On Thursday May 16th, a CeBIL delegation met with the management team from the SBDS (Structure, Bioinformatics & Data Science) group at Novo Nordisk. After that, CeBIL Director Professor Timo Minssen gave a one hour lecture on CeBIL and the legal implications of new digital technologies in the auditorium of Novo Nordisk’s Global Research Technologies and Global Drug Discovery unit.